Scarica l'app Stockscreener
0.2998
9.02%
0.0248
Dopo l'orario di chiusura:
.29
-0.0098
-3.27%
Precedente Chiudi:
$0.275
Aprire:
$0.2755
Volume 24 ore:
1.38M
Relative Volume:
0.26
Capitalizzazione di mercato:
$4.01M
Reddito:
$142.00K
Utile/perdita netta:
$-1.23M
Rapporto P/E:
0.6438
EPS:
0.4657
Flusso di cassa netto:
$-10.62M
1 W Prestazione:
+7.46%
1M Prestazione:
-17.71%
6M Prestazione:
-84.22%
1 anno Prestazione:
-90.70%
Intervallo 1D:
$0.2732
$0.3019
Intervallo di 1 settimana:
$0.2723
$0.3019
Portata 52W:
$0.2625
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Nome
Vivosim Labs Inc
Settore
Industria
Telefono
858-224-1000
Indirizzo
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
0.2998 | 3.68M | 142.00K | -1.23M | -10.62M | 0.4657 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-12-13 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Iniziato | Raymond James | Outperform |
| 2015-08-11 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Iniziato | Jefferies | Buy |
| 2015-06-29 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Vivosim Labs Inc Borsa (VIVS) Ultime notizie
VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials - Carroll County Mirror-Democrat
Received 5M from Eli Lilly - Moomoo
VivoSim Labs (NASDAQ: VIVS) Opens New Pharma Opportunity - Barchart.com
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
VivoSim Labs (VIVS) CCO buys 10,000 shares outside trading plan - Stock Titan
VivoSim plans rat liver model to complement human testing - Investing.com
VivoSim Labs to Add Rat Liver Model to NAMkind Platform - Yahoo Finance UK
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now - Barchart.com
Big Pharma giant Eli Lilly pays $6M to VivoSim Labs 🤯🔥 $Xiao-I (AIXI.US)$ $CID Holdco (DAIC.US)$ - Moomoo
VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum - Barchart.com
The Largest Pharma On The Planet Sent Cash to a Micro cap 👀 - Moomoo
VivoSim Labs Faces Nasdaq Minimum Bid Price Deficiency - TipRanks
VivoSim Labs Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VivoSim Labs, INC. SEC Filing (Aug 21, 2026) - Stock Titan
Warrants keep Esousa, Wachs’ VivoSim Labs (VIVS) stake under 10% - Stock Titan
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - Barchart.com
VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as - openPR.com
VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as Revenue Growth Guidance Tops 500% – Plus More In Focus - FinancialContent
VivoSim Labs (VIVS) seeks approval for reverse split, equity plan and warrant repricing - Stock Titan
VivoSim: Fiscal Q1 Earnings Snapshot - marketscreener.com
Oversold Stocks TOON, RMCF, PRSO, OFAL Offer Opportunity – See Why Inside - FinancialContent
VivoSim Labs Ord Shs (VIVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
$VIVS Load up 🔥🚀 - Moomoo
VivoSim Labs, INC. SEC Filing (Aug 11, 2026) - Stock Titan
VivoSim Labs (NASDAQ: VIVS) seeks approval for reverse split, warrant share issuance - Stock Titan
VivoSim Labs (VIVS) Revenue BreakdownMain Composition - Moomoo
VivoSim Labs (VIVS) News Flow - Moomoo
VIVS PE Ratio & Valuation, Is VIVS Overvalued - Intellectia AI
VIVOSIM LABS Q1 2026 Earnings Preview: Recent $VIVS Insider Trading, Hedge Fund Activity, and More - Moomoo
Stock Splits Calendar for: - Yahoo! Finance Canada
VivoSim Labs regains Nasdaq compliance after cash infusion By Investing.com - Investing.com UK
VivoSim Labs Regains Nasdaq Compliance, Boosts Cash to $10.1M and Projects 500%+ Revenue Growth for 2027 - Minichart
VivoSim Labs regains Nasdaq compliance after cash infusion - Investing.com
🍋💦🍋💦💣🚀 - Moomoo
VivoSim Provides Financial and Listing Compliance Update - The Manila Times
VivoSim regains Nasdaq compliance after $10.1 million cash update - Quiver Quantitative
VivoSim Labs Regains Nasdaq Compliance After $6M Milestone and $4M Financing - TradingView
VivoSim reports 13.4M shares outstanding after July warrant exercises - Stock Titan
VivoSim Labs issues 9,896,718 shares on warrant exercises - Bitget
IPO Databook: VivoSim Labs (VIVS US)Jul 2026 - Smartkarma
VivoSim Labs Sets 2026 Annual Shareholder Meeting Date - The Globe and Mail
VivoSim Labs, Inc. Revenue Breakdown – NASDAQ:VIVS - TradingView
VivoSim Labs (VIVS) Dips 6.89% as Stock Tests Key Support at $0.40Straddle Setup - vinanet.vn
VIVS|VivoSim Labs Ord Shs|Price:0.413|Chg%:-0.037 - TradingKey
VivoSim Labs Addresses Nasdaq Listing Compliance Concerns - TipRanks
VIVS|VivoSim Labs Ord Shs|Price:0.282|Chg%:-0.035 - TradingKey
VivoSim Labs, Inc. (VIVS) Stock Price, News, Quote & History - Yahoo! Finance Canada
VivoSim Labs, Inc. (VIVS) stock price, news, quote and history - Yahoo Finance UK
VivoSim Labs (VIVS) Holds Steady Near Support at $0.45 Amid Low VolatilityFactor ETF Flow - dars.gov.et
VIVS Expands into China with First Commercial Sales - GuruFocus
Vivosim Labs Inc Azioni (VIVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):